Journey Medical Corporation (DERM) Financials

DERM Assets vs Liabilities

Date	Assets	Liabilities
June 30, 2026	98.4 million	66.2 million
March 31, 2026	91.5 million	60.7 million
Dec. 31, 2025	94.6 million	62.7 million
Sept. 30, 2025	85.2 million	59.3 million

DERM Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.

Date	Free Cash Flow	Stock based compensation
June 30, 2026	-1.7 million	1.4 million
March 31, 2026	2.9 million	989000
Dec. 31, 2025	-6.3 million	1.8 million
Sept. 30, 2025	-2.4 million	1.9 million

DERM Net Income

No data available :(

DERM Cash and Debt

Graph available only for paid members. Upgrade to see it.

Date	Cash	Debt	Capital Lease
June 30, 2026	25.6 million	20.5 million	-
March 31, 2026	27.2 million	22.9 million	94000
Dec. 31, 2025	24.1 million	25.3 million	119000
Sept. 30, 2025	24.9 million	19.5 million	142000

DERM Shares Outstanding

Graph available only for paid members. Upgrade to see it.

Date	Shares Outstanding
June 30, 2026	27.5 million
March 31, 2026	27.3 million
Dec. 31, 2025	24.5 million
Sept. 30, 2025	25.0 million

DERM Expenses

Graph available only for paid members. Upgrade to see it.

Date	Capex	R&D	G&A	S&M
June 30, 2026	-	54000	10.9 million	-
March 31, 2026	-	-	10.1 million	-
Dec. 31, 2025	-	154000	9.9 million	-
Sept. 30, 2025	-	287000	12.1 million	-

DERM Cost of Revenue

Graph available only for paid members. Upgrade to see it.

Date	Revenue	Cost of Revenue
June 30, 2026	18.5 million	6.1 million
March 31, 2026	16.0 million	7.3 million
Dec. 31, 2025	16.1 million	6.5 million
Sept. 30, 2025	17.6 million	5.8 million

DERM Revenue by Segment

Graph available only for paid members. Upgrade to see it.

DERM

Price: $4.95

52 week price:

4.31

9.56

Earnings Per Share: -0.21 USD

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 25200

Ebitda: -176.2 million

Market Capitalization: 165.7 million

Links:

DERM on Yahoo Finance